Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind StudyAlison Stopeck, Ada Braun, María Eugenia Ibarrarán Viniegra et al.|Journal of Clinical Oncology|2010Cited by 1.6k
Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic AcidMiguel Martín, Ada Braun, Richard H. Bell et al.|Clinical Cancer Research|2012Cited by 145
2LBA Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 studyAlison Stopeck, J.J. Body, Yasuyuki Fujiwara et al.|European Journal of Cancer Supplements|2009Cited by 84
A Comparison of Denosumab Versus Zoledronic Acid for the Prevention of Skeletal-Related Events in Breast Cancer Patients with Bone Metastases.Alison Stopeck, Ada Braun, Richard de Boer et al.|Cancer Research|2009Cited by 21
P3-16-07: Denosumab in Patients with Breast Cancer and Bone Metastases Previously Treated with Zoledronic Acid or Denosumab: Results from the 2-Year Open-Label Extension Treatment Phase of a Pivotal Phase 3 Study.A. Stopeck, Ada Braun, Allan Lipton et al.|Cancer Research|2011Cited by 15